Thrombolysis despite recent stroke: A case series

Stroke

Volumn 44, Issue 6, 2013, Pages 1736-1738

  Alhazzaa, Mohammed ^a   Sharma, Mukul ^a   Blacquiere, Dylan ^a   Stotts, Grant ^a   Hogan, Matthew ^a   Dowlatshahi, Dar ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Outcome; Recurrent stroke; Safety; sICH; Silent stroke; Thrombolysis

Indexed keywords

ALTEPLASE;

AGE; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; CASE STUDY; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEMORRHAGIC TRANSFORMATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE CEREBRAL ARTERY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC DISEASE; PETECHIA; PRIORITY JOURNAL; RANKIN SCALE; SEX; STROKE PATIENT; TREATMENT OUTCOME;

OUTCOME; RECURRENT STROKE; SAFETY; SICH; SILENT STROKE; THROMBOLYSIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; RECURRENCE; RETROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84880169023     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.000818     Document Type: Article

References (15)

1. Demaerschalk BM. Challenging the validity of imposing contraindications to thrombolysis for acute ischemic stroke. Neurology. 2011;77:1862-1863.
2. Tong D. Are all IV thrombolysis exclusion criteria necessary? Being SMART about evidence-based medicine. Neurology. 2011;76:1780-1781.
3. Karlinski M, Kobayashi A, Mikulik R, Sanak D, Wahlgren N, Czlonkowska A; SITS-EAST Collaborative Group. Intravenous alteplase in ischemic stroke patients not fully adhering to the current drug license in Central and Eastern Europe. Int J Stroke. 2012;7:615-622.
4. Topakian R, Gruber F, Fellner FA, Haring HP, Aichner FT. Thrombolysis beyond the guidelines: two treatments in one subject within 90 hours based on a modifed magnetic resonance imaging brain clock concept. Stroke. 2005;36:e162-e164.
5. Ribo M, Molina CA. Repeated tissue plasminogen activator treatment for early stroke recurrence: protocol violation is not an option. Stroke. 2006;37:1151-2; author reply 1152.
6. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317-1329.
7. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke. Stroke. 2007;38:1655-1711.
8. De Keyser J, Gdovinová Z, Uyttenboogaart M, Vroomen PC, Luijckx GJ. Intravenous alteplase for stroke: beyond the guidelines and in particular clinical situations. Stroke. 2007;38:2612-2618.
9. Aleu A, Mellado P, Lichy C, Köhrmann M, Schellinger PD. Hemorrhagic complications after off-label thrombolysis for ischemic stroke. Stroke. 2007;38:417-422.
10. Mishra NK, Ahmed N, Davalos A, Iversen HK, Melo T, Soinne L, et al.; SITS and VISTA collaborators. Thrombolysis outcomes in acute isch-emic stroke patients with prior stroke and diabetes mellitus. Neurology. 2011;77:1866-1872.
11. Saini M, Ikram K, Hilal S, Qiu A, Venketasubramanian N, Chen C. Silent stroke: not listened to rather than silent. Stroke. 2012;43:3102-3104.
12. Tisserand M, Le Guennec L, Touzé E, Hess A, Charbonnier C, Devauchelle AD, et al. Prevalence of MRI-defned recent silent ischemia and associated bleeding risk with thrombolysis. Neurology. 2011;76:1288-1295.
13. Gaillard N, Schmidt C, Costalat V, Bousquet JP, Heroum C, Milhaud D, et al. Hemorrhagic risk of recent silent cerebral infarct on prethrombolysis MR imaging in acute stroke. AJNR Am J Neuroradiol. 2012;33:227-231.
14. Brigo F, Bovi T, Tomelleri G, Bovi P, Moretto G. Repeated systemic thrombolysis after early recurrent stroke: always hazardous? Can J Neurol Sci. 2012;39:114-116.
15. Cappellari M, Tomelleri G, Carletti M, Bovi P, Moretto G. Intravenous thrombolysis on early recurrent cardioembolic stroke: 'Dr Jekyll' or 'Mr Hyde?' Blood Coagul Fibrinolysis. 2012;23:78-81.